📌 Key Takeaways
- Topic: Colloidal Silica Supplier: How to Choose by Particle Size, Stability and pH
- Keywords: silica for powder coatings
- Published: 2026-11-20 06:45:05
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for Skincare: Benefits for Oil Control, Texture and Soft-Focus Effects
- Precipitated Silica Supplier: How to Compare Grades, Pricing and Reliability
- Considering these components, substantial efforts have been conducted to go for particular surface functionalization modifications of MSNs to decrease their toxicity such as neurotoxicity, immunotoxicity, and systemic toxicity (Fig. 6a ). A common approach is to integrate the biocompatible polymers with MSNs. Polymers including polyethylene glycol (PEG), polyethylenimine (PEI) and chitosan have been demonstrated to be excellent surface coating agents for MSNs, which can substantially enhance the in vivo circulation time, decrease cytotoxicity and hemolytic effect of MSNs. 295, 296, 297, 298 In terms of decreasing protein adsorption and boosting the colloidal stability of the particles, PEG is at present considered as an extremely excellent polymer. 298, 299, 300 Hao et al. systematically investigated the hemolytic activity and protein adsorption behavior of bare MSNs, MSNs modified with chitosan (MSNs-CS) and MSNs co-modified with chitosan and PEG (MSNs-CS-PEG). 301 Results showed that the hemolysis percentage and protein adsorption of MSNs-CS-PEG were 2% and 3.2%, respectively, which were remarkably lower than those of bare MSNs (30.9% and 14.5%, respectively), and they also exhibited lower toxicity toward MCF-7 cells. 301 This was similarly demonstrated in a study by He et al. 302 As well as polymers, liposomes have the advantages of high biocompatibility, low immunogenicity and long circulation, thereby they can also be used to enhance the biosafety of MSNs. 303, 304, 305 MSNs can be encapsulated by lipid bilayers or multilayers, and these liposomes act as protective shells to reduce toxicity by masking the reactive groups on the surface of MSNs. Compared to bare MSNs, liposome-encapsulated MSNs exhibit superior particle dispersion and lower non-specific binding. 306, 307 Additionally, they lead to the higher bioavailability and the in vivo half-life can be prolonged more than 10-fold, reducing the distribution of MSNs in reticuloendothelial system (RES)-related organs. 306 Protein coating is also a way to boost the biocompatibility and particle stability of MSNs. 308, 309 Negatively charged bull serum albumin (BSA), which is highly physiologically stable during blood circulation, can tightly bind to the amino groups on the MSNs surface, preventing the premature release of drug loaded on the MSNs. 309 Apart from, given that the positively charged MSNs show significant toxicity influence, some researchers have devoted to regulating the surface properties of MSNs by direct group modification. The surface potential of MSNs can be regulated by diverse functionalization via carboxyl (-COOH), phenyl (-Ph), and methyl phosphonate (-PO 3 - ) groups with negative and neutral zeta potentials. 310, 311
- Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
- Carmona, D., Balas, F. & Santamaria, J. Pore ordering and surface properties of FDU-12 and SBA-15 mesoporous materials and their relation to drug loading and release in aqueous environments. Mater. Res. Bull. 59, 311-322 (2014). Post CAS Google Scholar
- Silica Price Forecast: What to Expect for 2026–2027
- Wang, F., Wang, J. & Liu, X. Direct evidence of a surface quenching effect on size‐dependent luminescence of upconversion nanoparticles. Angew. Chem. Int. Ed. 49, 7456-7460 (2010). Article CAS Google Scholar
- Silica 99% Purity: Specifications, Grades and Typical Applications
Silica vs Silicon: What Is the Difference?
What is silica (SiO₂)?
kaolin
What is the difference between fumed silica and precipitated silica?
silicon dioxide common name
What drives silica raw material prices?
silica carrier for pesticides Firstly, even though several silica-based nanoformulations have already proceeded to the clinical trial stage and have been shown to be remarkably efficacious and acceptably secure, this is not virtually enough given the tremendous cost researchers have put in upfront. The most crucial consideration driving the successful clinical translation is a comprehensive and systematic toxicity study of MSNs. Despite the fact that a relatively finalize set of toxicity studies on MSNs has been established in the scientific community, a sustained effort is still needed. It is noteworthy that many of the currently designed therapeutic systems for MSNs are disconnected from systematic toxicological evaluations. Some researchers have focused more on the therapeutic impacts, but the feasible MSNs-based nanocomposites constructed on this basis are far from the silica NPs used by another part of the researchers in MSNs toxicology evaluation. In future research, under the premise of guaranteeing the efficacy of MSNs-based nanomedicines, more focus on the toxicological evaluation and long-term biosafety assessment of MSNs will be more useful to promote the possibility of their clinical translation.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.